Hester Biosciences Limited
Hester Biosciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: HESTERBIO and BSE: 524669 (ISIN INE782E01017).
It has a market capitalisation of ₹1,928 crore, a last close of ₹2,267 on 2026-10-19, a one-year return of 32.3%.
Valuation: a price-to-earnings ratio of 14.16x, a price-to-book ratio of 5.35x, a dividend yield of 0.5%.
Profitability: return on equity of 16.5%, return on capital employed of 15.3%, an operating margin of 26.6%.
Growth: sales growth of 7.7% a year over three years, net profit growth of 27.8% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.52x, promoter holding of 44.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,928 |
| Last close | ₹2,267 |
| P/E (TTM) | 14.16x |
| P/B | 5.35x |
| Dividend yield | 0.5% |
| ROE (FY) | 16.5% |
| ROCE (FY) | 15.3% |
| Operating margin (TTM) | 26.6% |
| Sales growth, 3-year CAGR | 7.7% |
| Profit growth, 3-year CAGR | 27.8% |
| Debt / equity | 0.52x |
| Promoter holding | 44.3% |
| 1-year return | 32.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means